Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
25.70
-0.23 (-0.89%)
Apr 9, 2026, 12:25 PM EDT - Market open
Surrozen Employees
Surrozen had 44 employees as of December 31, 2025. The number of employees increased by 3 or 7.32% compared to the previous year.
Employees
44
Change (1Y)
3
Growth (1Y)
7.32%
Revenue / Employee
$79,023
Profits / Employee
-$5,500,591
Market Cap
295.21M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 44 | 3 | 7.32% | 44 | 0 |
| Dec 31, 2024 | 41 | -1 | -2.38% | 40 | 1 |
| Dec 31, 2023 | 42 | -32 | -43.24% | 42 | 0 |
| Dec 31, 2022 | 74 | -9 | -10.84% | 74 | 0 |
| Dec 31, 2021 | 83 | - | - | 83 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| LENZ Therapeutics | 152 |
| Adagene | 138 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Protara Therapeutics | 46 |
| Inhibikase Therapeutics | 35 |
| Anavex Life Sciences | 34 |
SRZN News
- 16 days ago - Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Surrozen to Present at Upcoming Healthcare Investor Conference - GlobeNewsWire
- 6 weeks ago - Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 5 months ago - Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 months ago - Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway - GlobeNewsWire